Item 1.01 Entry into a Material Definitive Agreement.
On
The Underwriting Agreement contains customary representations, warranties, and covenants of the Company and also provides for customary indemnification by each of the Company, the Selling Stockholders, and the Underwriters against certain liabilities and customary contribution provisions in respect of those liabilities.
The sale of the Common Stock by the Selling Stockholders was made pursuant to
the Company's Registration Statement on Form S-3 (Registration No. 333-228559),
including a prospectus supplement dated
The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, datedDecember 1, 2020 , by and amongSyneos Health, Inc. , the selling stockholders named therein andGoldman Sachs & Co. LLC andBofA Securities, Inc. 5.1 Opinion ofLatham & Watkins LLP . 23.1 Consent ofLatham & Watkins LLP (included in Exhibit 5.1). 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source